Anthrax in America 2001-2003

Journal of the National Medical Association

Volumn 96, Issue 3, 2004, Pages 344-350

  Joshi, Shivang G ^b,e   Cymet, Holly Berkovits ^c,d   Kerkvliet, Gary ^d   Cymet, Tyler ^a,b  

^a Department of Internal Medicine ^*  (United States)

^b SINAI HOSPITAL OF BALTIMORE   (United States)

^c MERRIMACK COLLEGE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ST GEORGE S UNIVERSITY SCHOOL OF MEDICINE   (Grenada)

Author keywords

Anthrax; Anthrax vaccine; Bacillus anthracis; Biological terrorism; Cutaneous anthrax; Inhalational anthrax

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTHRAX VACCINE; AZTREONAM; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORINASE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; MEROPENEM; PENICILLIN G; PENICILLINASE; PROCAINE PENICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTHRAX; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL STRAIN; BIOLOGICAL WARFARE; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG MECHANISM; ENVIRONMENTAL EXPOSURE; EPIDEMIC; GENETIC ENGINEERING; HISTORY; HUMAN; INCIDENCE; LIFE CYCLE; MULTIDRUG RESISTANCE; PATHOGENESIS; POLITICS; POPULATION EXPOSURE; POSTAL MAIL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLISHING; STRAIN DIFFERENCE; UNITED STATES; VACCINATION;

ANTHRAX; BACILLUS ANTHRACIS; HUMANS; UNITED STATES; VACCINATION;

EID: 1442355845     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Investigation of bioterrorism-related anthrax: Connecticut, 2001. MMWR Morb Mortal Wkly Rep. 2001;50:1077-1079.
2. Cymet TC, Kerkvliet GJ, Tan JH, et al. Symptoms associated with anthrax: suspected "aborted" anthrax. JAOA. 2002;102:41-43.
3. Dirckx JH. Virgil on anthrax. Am J Dermatopathol. 1981;3: 191-195.
4. Koch R. Die Aetiologie der Milzbrand-Krankheit, begrundet auf die Entwicklungsgeschichte des Bacillus anthracis [in German]. Beitrage zur Biologie der Pflanzen. 1876;2:277-310.
5. La Force FM. Woolsorters' disease in England. Bull NY Acad Med. 1978;54:956-963.
6. Inglesby TV, Henderson DA, Bartlett JG, et al. Working Group on Civilian Biodefense [consensus statement]. Anthrax as a biological weapon: medical and public health management. JAMA. 1999;282:1624-1625.
7. Friedlander A. Anthrax Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. 1997;467-478.
8. Druett HA, Henderson DW, Packman L, et al. Studies of respiratory infection: the influence of particle size on respiratory infection with anthrax spores. J Hyg (Lond). 1953;51:359.
9. Edwards MS. Anthrax. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 3rd ed. Vol. 1. 1992;1053-1056.
10. Haight TH. Anthrax Meningitis. Am J Med. 1960;29:992-1001.
11. Davies JCA. A major epidemic of anthrax in Zimbawbe, III: Distributions of cutaneous lesions. Cent Afr J Med. 1983;29:8-12.
12. de Vos V. The ecology of anthrax in the Kruger National Park, South Africa. Salisbury Med Bull Suppl. 1990;68:19-23.
13. Titball R, Turnbull P, Hutson R. The monitoring and detection of Bacillus anthracis in the environment. Soc Appl Bacteriol Symp Ser. 1991;20:9s-18s.
14. Brachman P, Friedlander A. Anthrax. In: Plotkin S, Orenstein W, eds. Vaccines, 3rd ed. Philadelphia, PA: WB Saunders Co.; 1999:629-637.
15. Summary of notifiable diseases, 1945-1994. MMWR Morb Mortal Wkly Rep. 1994;43:70-78.
16. Vietri NJ, Marrero R, Hoover T, et al. Identification and characterization of a transactivator involved in the regulation of encapsulation by Bacillus anthracis. Gene. 1995;152:1-9.
17. Human anthrax associated with an epizootic among livestock-North Dakota, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:1077.
18. Fujikura T. Current occurrence of anthrax in man and animals. Salisbury Med Bull Supll. 1990;68:1.
19. Brookemeyer R, Blades N, Hugh-Jones M, et al. The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak. Biostatistics. 2001;7:233-247.
20. Brachman P, Friedlander A. Inhalation anthrax. Ann NY Acad Sci. 1980;353;83-93.
21. Guidi-Rontani C, Weber-Leavy M, Labruyer E, et al. Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol. 1999;31:9-17.
22. Ross JM. The pathogenesis of anthrax following the administration of spores by the respiratory rout. J Pathol Bacteriol. 1957;73:485-494.
23. Dixon TC, Meselson M, Guillemin J. Anthrax: review article. Medical Progress. 1999;341:815-826.
24. Henderson DW, Peacook S, Belton FC. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. JHyg. 1956;54:28-36.
25. Friedlander AM, Welkos SL, Pitt ML, et al. Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis. 1993;167:1239-1242.
26. Glassman H. Industrial inhalation anthrax. Bacteriol Rev. 1966;30:657-659.
27. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202-1208.
28. Young AT, Collier RJ. Attacking anthrax. Scientific American: Feature Article, March 2002. Available at: http://www.sciam.com/ 2002/0302issue/0302young.html. Accessed Dec 10, 2002.
29. Tang Wei-Jen. The road to find an antidote to anthrax infection. APS Colloquim: April 2002. Available at: http://ben-may.bsd. uschicago.edu/bmi/faculty/tang.html. Accessed Dec 10, 2002.
30. Hana PC, Acosta D, Collier RJ. On the role of macrophages in anthrax. Proc Natl Acad Sci USA. 1993;90:10198-10201.
31. Soviet Biological Warfare Threat Washington, DC: Defense Intelligence Agency, U.S. Dept of Defense, 1986. Publication DST-161of-057-86.
32. Peter CJ, Hartley DM. Anthrax in inhalation and lethal human infection. Lancet. 2002;359:710-711.
33. Jernigan J, Stephens D, Ashford A, et al. Bioterrorism-related inhalation anthrax: the first 10 cases reported in the United States. Emerging Infectious Diseases. 2001;7:933-943.
34. Abramov F, Grinberg L, Yampolskaya V, et al. Pathology of inhalation anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA. 1993;90:2291-2294.
35. Rangel R, Gonzalez DA. Bacillus anthracis meningitis. Neurology. 1975;525-530.
36. Walker JS, Lincoln RE, Klein F. Pathophysiological and biochemical changes in anthrax. Fed Proc. 1967;26:1539-1544.
37. Freedman A, Afonja O, Chang M, et al. Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a seven-month-old infant. JAMA. 2002;287:869-874.
38. Kaye E, Kaye K. Fever and rash. In: Braunwald E, Faucci AS, Isselbacher KJ, et al., eds. Harrison's Textbook of Medicine. NewYork, NY: McGraw-Hill; 2001.
39. Sirisanthana T, Navachareon N, Tharavichitkul P, et al. Outbreak of oral-pharyngeal anthrax. Am J Trop Med Hyg. 1984; 33:144-150.
40. Parry Jm, Turnbull PCB, Gibson JR. A color atlas of Bacillus species. London: Wolfe Medical. 1983:272.
41. Kinsely RF. Selective medium for Bacillus anthracis. J Bacteriol. 1966;92:784-786.
42. William R. Bacillus anthracis and other spore-forming bacilli. In: Braude AI, Davis LE, Firer J, eds. Infectious Diseases and Medical Microbiology. Philadelphia, Pa: WB Saunders Co. 1986;270-278.
43. Notice to readers: considerations for distinguishing influenza-like illness from inhalation anthrax. MMWR Morb Mortal Wkly Rep. 2001;50:984-986.
44. Munoz FM, Galasso GJ, Gwaltney JM, et al. Current research on influenza and other respiratory viruses, II International Symposiun. Antiviral Res. 2001;21;79-83.
45. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy. MMWR Morb Mortal Wkly Rep. 2001;50:909-919.
46. Franz Dr, Jharling PB, Friedlander A, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 1997;278:399-411.
47. Stepanov AV, Marinin LI, Pomerantsev AP, et al. Development of novel vaccines against anthrax in man. J Biotechnol. 1996;44:155-160.
48. Stevens DL, Gibbons AE, Bergstron R, et al. The Eagle effect revisited. J Infect Dis. 1988;158:23-28.